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1. Introduction 
 
Preclinical animal models provide critical information to better understand human diseases’ characteristics, 
identify biomarkers, develop diagnostic tools and novel therapeutics. Rabbits and laboratory rodents (mice, 
rats) are widely used for ophthalmic research as they are economical and easy to handle;1 however, serious 
drawbacks limit the translational usefulness of data obtained in these species, notably due to the need to 
artificially induce pathology in these animals (eg., through genetic manipulation or experimental surgery), 
as well as apparent differences in ocular anatomy and physiology compared to humans. For instance, 
precorneal residence time of topically applied solutions is much prolonged in rabbits owing to their low 
blink rate, resulting in 3-fold overestimation of ocular drug exposure if findings were directly extrapolated 
from rabbits to humans.2 Another example is topical nepafenac, a potent nonsteroidal anti-inflammatory 
drug (NSAID) that reaches therapeutic levels in the posterior segment of mice (owing to their thin cornea 
and small globe size), inhibiting choroidal neovascularization by decreasing production of VEGF3 – in 
contrast, humans require intravitreal injections of anti-VEGF compounds to achieve the same outcome. 
Multiple other examples exist in the scientific literature, together participating to the unacceptably low 
success rate of ophthalmic clinical trials to date, and resulting in substantial economic loss and burden for 
scientists, consumers, and society overall.4 In fact, the main cause for clinical trial failure is either lack of 
safety or efficacy,5 two components that are supposedly ‘validated’ in initial preclinical animal studies. 
 
Under the umbrella of the One Health Initiative, a growing number of investigations have integrated 
companion animals into preclinical studies to complement and expand the knowledge gained from studies 
in other animal models, accelerate and improve the framework in which research is translated to the human 
clinic, and ultimately generate discoveries that will benefit the health of humans and animals.6 Over the last 
few years, several review articles have highlighted the benefits of using dogs for translational research in 
oncology,7 neurology8 and other biomedical fields,6 yet such information is not available in ophthalmology. 
 
The present review provides a comprehensive comparison of key ocular parameters in humans, dogs and 
traditional laboratory animals (ie., rabbits, mice, rats), highlighting selected strengths and important pitfalls 
that must be addressed when ocular research is conducted in animal models. This review is focusing on the 
ocular surface, a critical element of vision that includes the secreted tear film, lacrimal gland(s), eyelids, 
meibomian glands, cornea, conjunctiva, sclera, and nasolacrimal drainage apparatus. The ocular surface 
dictates the bioavailability of medications administered topically to the eye,9 and is a common site of 
pathology in both human and veterinary medicine. Methods of tear fluid collection for bioanalytical 
purposes are also being discussed, with special consideration on the safety and efficiency of the collection 
technique at hand. Lastly, this review highlights on spontaneous and experimental ocular surface disorders 
in dogs, providing a tool for researchers to better model disease pathophysiology in clinical patients 
suffering from ocular surface disorders. 
 
2. Comparative anatomy and physiology of the ocular surface  
 
2.1. Anatomy 
 
The anatomy of the ocular surface is depicted in Figure 1 for dogs, and its parameters are being summarized 
in Table 1 for all species discussed in this review (ie., humans, dogs, rabbits, mice, rats).  
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 Lacrimal glands - Four types of lacrimal glands can be distinguished in mammals: (i) the orbital lacrimal 
gland (glandulae lacrimales superior), located in the dorsolateral orbit just caudal to the orbital rim, with 
secretory ducts that open into the upper conjunctival fornix (humans, dogs, rabbits); (ii) the gland of the 
third eyelid, located in the ventromedial orbit at the base of the nictitating membrane with secretory ducts 
than open into the nictitans’ bulbar conjunctiva (dogs); (iii) the infraorbital gland (glandulae lacrimales 
inferior), located either intraorbital and ventromedial to the globe (rabbits) or extraorbital and caudal to the 
globe (rodents), with a single secretory duct that opens into the lower conjunctival fornix; and (iv) the 
Harderian gland, or Harder’s gland, extending from the base of the third eyelid into the caudal orbit, with 
secretory ducts opening at the nictitating membrane (rabbits, rodents).10,11 The histomorphology of lacrimal 
glands varies with age and sex of the individual.12 In dogs, an orbital lacrimal gland and gland of the third 
eyelid contribute to 60-70% and 30-40% of the overall tear secretion, respectively.13 The morphological 
and histological features of the canine glands resemble the human lacrimal gland including distinct lobules 
and acini that provide serous and mucous secretions, as well as intralobular ducts that drain into small 
excretory tubules.14,15 Likewise, an Harderian gland is not present in the canine or human orbit.14-16 
However, two notable differences exist between species: (i) the combined volume of the two canine glands 
is smaller than the main lacrimal gland in humans (0.24 vs. 0.60 cm2)17,18; and (ii) the accessory lacrimal 
glands of Krause and Wolfring are absent in dogs (or not yet reported), presumably being consolidated 
through evolution into the single gland of the third eyelid.19 These accessory glands account for 10% of the 
total lacrimal secretory mass in humans but their contribution to the overall tear secretion is negligible (1-
2%).20,21 In rabbits, the histoarchitecture of the main lacrimal gland is comparable to humans with loosely 
packed acini and round/oval lumen; in contrast, mice and rats have densely packed acini with small 
pleiomorphic lumen and numerous intercellular tight junctions.22 Like humans, rabbits also possess 
accessory lacrimal glands of Wolfring in the tarsal portion of the palpebral conjunctiva.23 However, the 
Harderian gland present in rabbits and rodents is a unique anatomical feature that has important 
repercussions for comparative studies; in fact, the gland’s lipid secretions in the tear film have profound 
effects on the ocular surface physiology (eg., tear composition, tear film dynamics, blink rate) and 
pharmacology of topically applied medications (see sections 2.2 and 2.3). 
 
Nasolacrimal apparatus - The morphology of the canine lacrimal drainage system is remarkably similar to 
that of humans, except for a longer nasolacrimal duct (notably in long-nosed dogs), and the presence of 
accessory duct openings into the nasal cavity.24 In both species, tear drainage begins with the lower and 
upper nasolacrimal puncta and canaliculi in the medial canthus, joining into a lacrimal sac in the bony 
lacrimal fossa, and extending into the nasolacrimal duct that runs through an osseous channel towards the 
nasal cavity.25 Species similarities are also evident on a microscopic level, including an epithelial lining 
with microvilli and mucin-secreting goblet cells, sub-epithelial seromucous glands, and mucosal-associated 
lymphoid tissue.24 In contrast, the nasolacrimal apparatus of rabbits has distinct differences compared to 
humans. Rabbits only have a single nasolacrimal punctum/canaliculus (medial lower eyelid) and the 
nasolacrimal duct has two very distinct flexures due to the ventral deflection of the snout, a unique feature 
that results in a convoluted path for tear drainage.25,26 The fetal development of the rabbit’s nasolacrimal 
apparatus is also unique in mammals, more closely resembling reptiles vs. humans.27 At an ultrastructural 
level, the epithelium lining the duct is double-layered (similar to humans) but there are no goblet cells or 
subepithelial seromucous glands.28 Nonetheless, the use of the rabbit is still recommended as a practical 
model to characterize the nasolacrimal apparatus,29 albeit this choice is described as ‘less than ideal’ by the 
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authors. Mice and rats have a well-developed nasolacrimal apparatus that shares similar ontogenetic origin 
to humans,27 although the histological features are different. The duct lining is covered by a multi-layered 
stratified squamous epithelium with goblet cells but without sub-epithelial seromucous glands.25 
 
Third eyelid - The nictitating membrane (third eyelid) is a large fold of the conjunctiva that protrudes from 
the medial canthus over the anterior surface of the globe in many animals, including dogs, rabbits and 
rodents. The counterpart in humans is the plica semilunaris, a vestigial remnant in the form of a crescent-
like conjunctival fold in the medial canthus.11,30 Despite gross differences, both structures have important 
physio-morphological similarities such as the presence of goblet cells and lymphoid follicles, contributing 
to the lubrication and immune protection of the ocular surface.30 Nonetheless, the presence of a third eyelid 
should be considered in comparative studies as it could impact ocular examinations (eg., third eyelid 
protrusion from ocular irritation) or ocular drug delivery (eg., altered retention time of a contact lens),31 
among others. If required for ease of experimentation, a simple fixation of the nictitating membrane can be 
performed31 as an alternative to complete surgical removal,13,32,33 as the latter negatively impacts ocular 
surface homeostasis.13,34 
Eyelids - Similar to humans, the canine upper and lower eyelids are comprised of an outer dermis, tarsus, 
orbicularis oculi muscle, palpebral conjunctiva and secretory tissues including meibomian glands (20-40 
per eyelid), glands of Zeis and Moll.35,36 The main anatomical difference is the tarsal plate, which is 
comprised of dense fibrous tissue and cartilage-specific components in humans37 – providing a rigid internal 
support to the eyelids – compared to a much thinner and poorly-developed fibrous tissue in dogs.38 Also, 
the interpalpebral fissure area is approximately 20% larger in dogs (2.2 vs. 1.8 cm2)39,40, although the 
measurements of the palpebral fissure width depend on the dog’s size and body weight.40 
The palpebral opening in the rabbit is relatively small (10-16 mm),38,41,42 albeit much larger than mice (3.7-
5 mm)43 and rats (6-9 mm)44,45, with a shorter and thicker upper eyelid compared to the inferior palpebrae; 
consequently, the interpalpebral fissure area is 20% smaller in rabbits than in man (1.44 vs. 1.8 cm2).39 The 
meibomian gland ducts and acini are also larger in rabbits than mice and rats,46 but the overall volume and 
distribution of meibomian glands is different than in humans: the total meibomian gland volume in the 
human (39.5 mm3) is twice that of the rabbit (18.8 mm3), with a larger volume in the upper eyelid (man) 
compared to similar volumes in the upper and lower eyelids (rabbit).39  
 
Conjunctiva - The conjunctiva is a thin mucous membrane that serves important roles on the ocular surface 
including mucin secretion and immune surveillance. The anatomical subdivision of the conjunctiva is the 
same in humans, dogs, and common laboratory species (rabbits, rodents): the palpebral conjunctiva – lining 
the inside of the eyelids – reflects back at the level of the conjunctival fornix to form the bulbar conjunctiva, 
a region that covers the anterior portion of the sclera and attaches to the corneoscleral limbus.16 However, 
the amount of bulbar conjunctiva exposed (‘scleral show’) is notably larger in humans compared to animals 
given differences in eyelid opening and/or corneal diameter. Another important species difference is the 
presence of a nictitating membrane in animals (but not man), as the third eyelid is covered by conjunctiva 
on its anterior and posterior surfaces. As such, animals have two conjunctival fornices in the inferonasal 
region – one on each side of the third eyelid – and the overall conjunctival surface is generally larger in 
animals compared to humans. In dogs, the conjunctival area is supposedly larger than in humans given the 
depth of the canine conjunctival fornices and the amount of conjunctiva covering the canine nictitating 
membrane,47 although no objective data exist to date. In rabbits, the upper conjunctival fornix depth (20.36 
mm)48 is larger than in humans (15 mm),49 while the conjunctival area is reportedly comparable (13.34-
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18.48 vs. 17.65 cm2, respectively), although the measurements did not include the rabbit’s third eyelid 
(surgically removed by investigators).50  
Conjunctival goblet cells are distributed individually in humans, dogs and rabbits, in contrast to clustered 
organization in mice and rats.51,52 The distribution of goblet cells is overall similar in dogs and humans, 
with high density in the canine third eyelid and human plica semilunaris, relatively high density in the 
conjunctival fornices and palpebral conjunctiva, and lower density in the bulbar conjunctiva.30,52-56 In 
rabbits, the highest density is noted at the lid margin of both upper and lower palpebral conjunctivae,57,58 
while the density in the bulbar conjunctiva is generally higher than in humans (399-1576 cells/mm2 vs. 7-
979 cells/mm2).56,59 In addition to mucin-secreting goblet cells, the conjunctiva also contains an organized 
immune network termed conjunctiva-associated lymphoid tissue (CALT), a structure that plays a key role 
in protecting the ocular surface by initiating and regulating immune responses.60 The presence of lymphoid 
follicles was confirmed in the conjunctiva of most mammals studied by Chodosh and colleagues – including 
humans, dogs, rabbits – with the exception of mice and rats,61 although a later report detected lymphoid 
tissue in the nictitating membrane of BALB/c mice.62 At an ultrastructural level, specialized M cells are 
present in the epithelium overlying the conjunctival follicles in dogs63 and rabbits,64 similar to humans.65  
 
Cornea - The anatomy of the cornea is unique to each species with important differences in corneal 
dimensions and ultrastructural features (eg., thickness, collagen arrangement, nerve supply).11,38,50,66-70 First, 
the cornea is generally larger in dogs and rabbits compared to humans, while the dimensions are much 
smaller in mice and rats.41,44,71-77 As such, the relative amount of cornea and conjunctiva exposed on the 
ocular surface varies among species, an anatomical fact that has important implications in ocular 
pharmacology and other research fields; for instance, the surface area ratio of conjunctiva to cornea is two 
times smaller in rabbits (8.6-8.9) than humans (17.1), a finding that could largely explain species differences 
in drug penetration into the anterior chamber.50 Second, the corneal thickness varies among mammals and 
is generally correlated to the size of the animal.68 From highest to lowest, the mean central corneal thickness 
is 497-594 µm in dogs,68,78 505-563 µm in humans,79 354-407 µm in rabbits,41,79,80 159-170 µm in rats68,80 
and 90-137 µm in mice.68,74,80 The average canine cornea is only slightly thicker than in humans. In contrast, 
the thinner cornea in rabbits and rodents can limit the use of these laboratory species for selected 
experiments; for instance, cross-linking is discouraged in corneas thinner than 400 µm due to potential 
damage to the corneal endothelium or intraocular tissues.81  
On a structural level, the main layers of the cornea are the same in humans and animals (epithelium, stroma, 
Descemet membrane, endothelium) with the notable exception of the Bowman’s membrane.11,70 Bowman’s 
membrane is present in nearly all primates (including humans) and selected animals (eg., sheep, deer, 
giraffe),82 but is absent in dogs and common laboratory species.68,70,82 The number of layers and overall 
thickness of the corneal epithelium vary among species: humans (5-7 layers, 44-55 µm),79,83 dogs (6-9 
layers, 52-64 µm),70,71,78 rabbits (5-7 layers, 45-49 µm),38,79,83 rats (10-14 layers, 26-33 µm),84,85 and mice 
(13 layers, 37-46 µm).74 The corneal stroma, comprising nearly 90% of the total corneal thickness in most 
mammals, is primarily composed of collagen fibrils arranged in lamellae. While extensive collagen 
intertwining is noted in the majority of the corneal stroma in humans, it is only present in the anterior most-
aspect of the cornea in dogs and rabbits.86,87 Differences in collagen intertwining, along with the absence of 
Bowman’s membrane in laboratory species, explain the vast disparity in stiffness of the anterior stroma 
(16.2, 1.3 and 1.1 kPa) and posterior stroma (2.5, 0.5 and 0.4 kPa) in humans, dogs and rabbits, 
respectively.86,87 The elastic modulus of the cornea is reportedly higher in rodents, although the 
methodology used was different.88,89 Corneal rigidity should be considered in comparative studies in which 
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the biophysical attributes of the cornea are important (eg., wound healing, keratoprosthesis). The corneal 
endothelium shares a similar morphological blueprint among species (single cell layer, honey-comb 
pattern), while the cellular density varies from 3233 cells/mm2 in rabbits, 2875 cells/mm2 in mice, 2818 
cells/mm2 in dogs, 2732 cells/mm2 in humans, and 2242 cells/mm2 in rats.68,90  
The mammal cornea is the most densely innervated tissue in the body. Corneal nerves play important roles 
to maintain ocular surface health and homeostasis, including sensory functions (touch, pain, temperature), 
release of trophic neuropeptides, maintenance of the limbal stem cell niche, and activation of brainstem 
circuits to promote reflex blinking and lacrimation. From highest to lowest, the sensitivity of the cornea to 
mechanical stimulus is as follows: humans (0.2-1.0 g/mm2), rats (0.42-0.47 g/mm2), mice (0.59 g/mm2), 
dogs (2.16-2.9 g/mm2), and rabbits (6.21-10 g/mm2).2,91-95 The murine model is the most extensively studied 
of all laboratory species given gross similarities between mice and humans in corneal sensitivity and nerve 
architecture.67,96 The canine model is also studied in detail given shared features with humans in several 
spontaneous diseases such as diabetes mellitus, herpetic keratitis, and non-healing corneal ulcers;97-100 
importantly, investigators should account for the canine breed selected for the experiment as corneal 
sensitivity depends on the dog’s cephalic conformation.95 In regard to rabbits, two striking species 
differences exist: (i) Corneal sensitivity in rabbits is much lower than in humans, dogs and rodents;2,92 and 
(ii) Morphology of the rabbit subbasal plexus is unique, with nerve fibers sweeping horizontally across the 
corneal surface in a temporal-to-nasal direction compared to a typical whorl-like or spiraling pattern in 
other species.67  
  
Sclera - Humans have a widely exposed white sclera, a feature that is unique when compared to other 
primate species (Kobayashi, 1997). In contrast, the scleral exposure is minimal in dogs and routine 
laboratory species. The thickness of the sclera also differ among species: at the ocular surface (limbal 
sclera), recorded measurements vary from 0.8 mm in dogs,101 0.5 mm in humans,102 0.29 mm in rabbits,103 
0.1 mm or less in rats,104 and 0.05-0.06 mm in mice.105 
 
2.2. Tear film dynamics  
 
Effective tear dynamics, combined with well-balanced composition of the tear film (discussed in the next 
section), are critical for the maintenance of ocular surface homesostasis and physiology. Tear fluid 
dynamics – or the balance between tear secretion, distribution, absorption, evaporation, and drainage – are 
closely regulated by the lacrimal functional unit. The lacrimal functional unit is unique to each species (see 
aforementioned anatomical differences), comprised of secreting glands (orbital, accessory, third eyelid, 
Harder’s, meibomian), eyelids, conjunctival goblet cells, corneo-conjunctival surface, and their 
interconnecting innervation.106 Key physiological parameters provide insight into the complex tear 
dynamics – highlighted in Figure 2 and Table 2 – and are therefore important to account for in translational 
studies that involve the ocular surface: 
 
• Basal tear turnover rate: Tear turnover rate is considered a global measure of the tear dynamics and 
integrity of the lacrimal functional unit.107,108 The basal tear turnover rate is reportedly 13.1-17.5 %/min 
in humans,109,110 12.1 %/min in dogs,111 6.2-7.1 %/min in rabbits112 and 5.2 %/min in mice;113 no 
information was available in rats. In other words, it takes approximately the same time for the tear film 
to replenish in dogs and humans (~6-8 min) but the duration is longer in rabbits (~14-16 min) and mice 
(~20 min). The slow tear turnover of rabbits and rodents has important repercussions in translational 
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research, including a longer precorneal retention time of instilled eyedrops (see next subsection), or 
exaggeration of ocular surface disease due to delayed clearance of inflammatory mediators from the 
tear film.114  
 
• Tear volume: The volume of tears on the ocular surface is highest in dogs (65.3 µL),111 followed by 
humans (7-12.4 µL),109,115 rabbits (1.9-7.5 µL)112,116 rats (4.6 µL)117 and mice (0.06-0.2 µL).113,118 
Canine tear volume depends on the subject’s body weight but not the dog’s cephalic conformation.111 
Differences in study methodology notwithstanding, the canine tear volume is approximately 5 to 9-fold 
larger than in humans. This discrepancy can be partly explained by the additional secretory tissue in 
dogs (third eyelid gland) and the larger corneal surface to lubricate in dogs (1.2-2.1 cm2 vs. 1.04-1.3 
cm2).50,71,77 The canine tear film may also be thicker than in humans (15.1 µm vs. 2.3-11.5 µm), although 
measurements of tear thickness were only obtained in 6 dogs111 and the calculation of tear thickness is 
reportedly highly variable within and between species.119  
 
• Spontaneous blink rate: The blink action distributes fresh tears on the ocular surface in a uniform layer, 
promotes secretion of tears from the accessory tear glands, and pumps excess tears (or instilled drop) 
into the nasolacrimal drainage system. Spontaneous blinking is triggered by higher centers in response 
to corneo-conjunctival nerve stimulation, presumably due to changes in ocular surface temperature that 
result from thinning and evaporation of unstable tear film.120 The spontaneous blink rate is very similar 
between dogs (14.2 blinks/min)121 and humans (8.5-17.6 blinks/min),122-124 although it is lower in 
rodents (< 5.3 blinks/min)91,124-126 and much lower in rabbits (0.05-0.19 blinks/min).2,123,127 In other 
words, humans and dogs blink approximately every 4-7 seconds, while mice/rats blink every 11 seconds 
(or more) and rabbits only blink every 313-1200 seconds. This large disparity in mammals’ blink rate 
can be explained by species differences in (i) ocular surface sensitivity, (ii) tear composition, and (iii) 
the inherent stability of the animal’s tear fluid. In fact, (i) the corneo-conjunctival sensitivity is higher 
in humans > rodents > dogs >> rabbits, a key parameter that is linked to spontaneous blinking as well 
as reflex secretion of tear components from the lacrimal glands, conjunctival goblet cells and 
meibomian glands;128 (ii) tear composition is unique to each species (see next section), for instance 
large discrepancies exist in the tear lipidomic profile of rabbits vs. man;129 and (iii) tear film stability is 
strongly associated with the maximum blink interval, as recently shown in humans.130 Tear stability is 
often measured with the tear film breakup time (TFBUT), defined as the interval between the last 
complete blink and the first appearance of a dry spot in the tear film. Results of TFBUT and other tear 
film diagnostics are summarized in Table 2, with care given to discard or highlight values obtained in 
anesthetized or sedated animals (eg., TFBUT of 29.8 min in sedated rabbits)131 as chemical intervention 
negatively impacts ocular surface homeostasis (ie., abolished blinking, reduced tear secretion). 
 
Importantly, investigators should account for additional parameters (and their species differences) in any 
study that involves topical drug administration. In fact, an eyedrop can be considered as a transient ocular 
irritant – especially if the solution’s pH or osmolarity is different than the tear film – thereby stimulating 
reflex blinking and lacrimation upon contact with the ocular surface.132 
 
• Reflex blinking (or lack thereof): In dogs, a blink occurs immediately after eyedrop administration and 
is responsible for removal of any excess solution onto the periocular skin and nasolacrimal drainage 
system.40 The same is true in humans, in whom an instilled eyedrop is partially lost (20-30%) due to 
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reflex blinking and spillage onto the eyelids and eyelashes.133 Blinking in response to eyedrop 
instillation is also reported in mice134 and rats.135 In contrast, rabbits rarely blink following eyedrop 
administration, or do so infrequently. In one study, rabbits did not blink for 20-30 minutes after 
instillation of an eyedrop, and this alone could result in overestimating ocular drug exposure by 3-fold 
if findings were to be extrapolated to humans.2  
 
• Reflex tear turnover rate: Eyedrop administration abruptly increases the volume of fluid in the 
conjunctival sac and ocular surface. The sudden disruption in homeostasis promotes a faster 
nasolacrimal drainage until baseline conditions return. This physiologic response is prominent in dogs 
(50 %/min)111 and humans,109,115 but is minimal in rabbits (6.1-6.9 %/min).112 In fact, the tear turnover 
rate in rabbits is mostly unchanged whether a small (1-5 µL) or large volume (25-50 µL) of eyedrop is 
instilled on the ocular surface,112 a finding likely related to the poor corneal sensitivity and 
inexistent/minimal reflex blinking in this species.2,92 No available report in mice or rats can be found 
in the literature. 
 
• Volumetric capacity of the palpebral fissure: The surface of the canine eye can ‘hold’ on average 31.3 
µL of fluid,40 nearly identical to the volumetric capacity of the human eye (25-30 µL)109,136 and the 
volume of a single ophthalmic drop (35 µL).137 Of note, the volumetric capacity of the canine eye is 
positively correlated with the length of the palpebral fissure,40 and may be larger in breeds larger than 
Beagles (eg., German Shepherd dogs).137 The exact volumetric capacity of the eye is not reported in 
laboratory species, but is presumably around 10-25 µL in rabbits (based on drug quantification in tears 
at various instilled volumes),112,138 ≤ 5 µL in mice139,140 and ≤ 20 µL in rats.141  
 
2.3. Tear film composition 
 
The tear film is a complex biological fluid containing thousands of compounds of diverse structures and 
functions, including proteins, lipids and mucins, as well as minor constituents such as electrolytes, vitamins, 
and growth factors.36,142 The integrated interactions of these constituents are responsible for the promotion 
of a stable tear film and, ultimately, the homeostasis of the ocular surface. Species differences in tear film 
components are summarized in Table 3.  
 
Proteins – The total protein content is generally similar in dogs (5.2-14.6 mg/mL)143 and humans (6.0-11.0 
mg/mL),144 although qualitative and quantitative differences exist. Specifically, the three major constituents 
of the human tear proteome (lactoferrin, lysozyme, lipocalin)144 are only detected at low levels in dogs,145-
150 although the relative abundance of other common proteins (eg., lacritin, secretory IgA, serum albumin) 
is generally similar between the two species. Importantly, homologous proteins have been described in 
canine tears and may play similar functions to their human counterparts – for instance, transferrin is an 
iron-binding protein with similarities to lactoferrin, while major canine allergen is an abundant protein in 
canine tears with similarities to lipocalin.148-150 From a qualitative aspect, a recent in-depth proteomic study 
showed that 25 out of 125 proteins detected in canine tears were common to humans.149 In rabbits, Wei et 
al. found that the total protein content was two-fold higher in rabbits compared with humans (20.6 mg/mL 
vs. 9.4 mg/mL), although the number of different proteins detected in tear samples was lower in rabbits.151 
Other differences in tear proteins among species are summarized in Table 3.  
 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 23 May 2020                   doi:10.20944/preprints202005.0363.v1
Mucins – Ocular mucins are large glycoproteins expressed by conjunctival goblet cells, the corneal 
epithelium and the lacrimal gland(s), playing important roles on the ocular surface in lubrication, wettability 
and barrier function.152 The main secretory mucin, MUC5AC, is described at large levels on the ocular 
surface of humans and animals.11,55,152 The expression of membrane-associated mucins, however, differs 
among species. In a recent study by Leonard et al., dogs were found to have a very similar pattern of mucin 
expression to that of humans and rhesus macaques, with MUC16 being the most abundant mucin 
transcript.153 In contrast, the rabbit had a unique mucin expression pattern with all mucin transcripts 
expressed at relatively similar levels; as such, the authors concluded that the predictive value of the rabbit 
as a model in ocular surface studies should be called into question.153 In another study, the majority of 
ocular mucins detected in dogs and rabbits were neutral fucosylated glycans, while the ones in humans were 
mainly negatively charged sialylated glycans;154 however, the experiment lysed the ocular surface 
epithelium and could not discriminate between mucins of differing origin.  
 
Lipids – In a comprehensive lipidomic study comparing the meibum collected in several species, Butovich 
et al. found that the highest degree of biochemical similarity with humans was observed in mice, closely 
followed by the dog.129 An earlier study by Butovich et al. also reported the close resemblance of the tear 
lipid composition between dogs and humans.155 In these 3 species (humans, dogs, mice), the major lipid 
classes included wax esters, cholesterol esters, and o-acyl-ω-hydroxy fatty acids (OAHFA). In contrast, the 
major lipid classes in rabbit tears were DiHL esters (24,25-dihydro--lanosterol esters), diacylated diols, and 
OAHFA, with low to trace amounts of wax and cholesterol esters.129 Such discrepancy between rabbits and 
humans was confirmed in a separate study by Wei et al, who noted significant differences in the tear film 
concentrations of triglycerides (higher in rabbits), free cholesterol (lower in rabbits), phosphatidylcholine 
(higher in rabbits) and phosphatidylethanolamine (higher in rabbits).151 Taken together, the authors of these 
two studies argued that the rabbit is too different to serve as a valid animal model for humans, at least from 
a biochemical standpoint. 
 
3. Tear collection for bioanalytical purposes  
 
The tear film, a complex body fluid uniquely exposed to both internal and external environments, 
contains numerous endogenous and exogenous molecules (eg., proteins, lipids, mucins, xenobiotic) that 
can be assayed for clinical or research purposes. Topically and systemically administered drugs can be 
quantified in tear fluid to determine the clinical efficacy and dosing frequency from fitting of kinetic data.156-
160 Multiple ‘omics’ approaches can also be utilized for analysis of the tear fluid including 
proteomics,149,150,161-166 lipidomics129,155,167,168 and metabolomics,168 providing valuable information for the 
development of novel diagnostics and therapeutics in ophthalmology, as well as biomarkers identification 
for various ocular and systemic diseases.169-171 However, collecting tears and obtaining reproducible 
analytical results in ophthalmology is challenging; in particular, the volume of tear fluid is limited (unlike 
other biological fluids, such as blood or urine), and the biochemical profile of a tear sample is intimately 
affected by the collection, storage, extraction, handling, and analytical methods used by the investigator. 
In this section, we review the main sampling methods reported in the scientific literature and discuss their 
respective advantages and limitations. Further, based on the authors’ experience with dogs in clinical and 
research settings (board-certified veterinary ophthalmologist [LS] and pharmacologist [JPM]), the section 
provides recommendations specific to canine subjects and their use in translational research (Figure 3). 
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3.1. Direct tear sampling 
 
A microcapillary glass tube (1-10 µL) placed in contact with the inferior lacrimal lake is the most 
commonly reported technique to collect tear fluid. This method directly samples tear fluid by capillary 
action and is extensively described in humans,144,161,166,172-185, dogs,147,150,186-189 rabbits,183,184,187,190,191 
mice,192,193 and rats.147,183,194,195 Other direct techniques (seldom reported) involve micropipettes,196 
polypropylene tubing147 or polytetrafluoroethylene tubing.172 With capillary glass tubes, it is possible to 
obtain unaltered tear samples by avoiding reflex tearing from ocular irritation, especially if the collection 
is performed by an experienced operator on a cooperative patient. The minimal binding of tear compounds 
to glass is another reported advantage of capillary tubes. However, the main limitation of microcapillary 
collection is the long collection time, generally ≥ 5 min174,180,184,185,190,193 – this is particularly true in small 
laboratory animals, with up to 15-30 minutes and 15-60 min required to collect sufficient tear fluid in 
rabbits184,190 and rodents (mice and rats),193,194 respectively. Another critical limitation of direct sampling is 
the low volume of tear fluid retrieved, generally ≤ 5 µL144,147,166,172,175,177-179,182,183,185,191-193 – as such, the 
small sample collected may be grossly insufficient in some individuals,144,188 may require excessive dilution 
that renders the target analyte undetectable,189 and does not take into account possible losses (eg., transfer, 
storage) or the need to repeat certain assays in duplicates.  
Several strategies can be used to overcome current obstacles with the volume of the tear volume; however, 
each come with its own set of drawbacks (listed in parentheses): (i) Sedate or anesthetize the animal to 
extend collection duration and obtain a larger volume (altered lacrimal functional unit and ocular surface 
homeostasis);147,184,190,192-195 (ii) Pool tear samples from several subjects (reduced statistical power and loss 
of information regarding inter-individual variability);161,187,192 (iii) Induce reflex tearing with a stimulant – 
either physical (eg.. irritation to nasal mucosa or cornea), chemical (eg., parenteral pilocarpine or 
ammonium fumes) or physiological (eg., yawn or sneeze reflex) – thereby accelerating tear flow and 
shortening collection time (diluted tear sample, unable to control flow rates);180,193,194,197 (iv) Instill fluid 
(eg., saline) on the ocular surface immediately prior to tear collection, a process called ‘flush’ or ‘washout’ 
that yields a larger tear sample in a shorter amount of time (diluted tear sample, non-standardized instilled 
volume, non-homogenous mixing of fluid with tears).174,180,192,193,195,197,198 In particular, the diluting effect 
of reflex tearing or flush methods may drop the concentration of low-abundant compounds below the 
analytical limit of quantification, and potentially mask differences between groups due to reduced variance 
in tear composition.174,199 A third limitation of microcapillary tubes is the technical difficulty associated 
with the collection method. In fact, it is nearly impossible (or very challenging) to avoid reflex lacrimation 
in a consistent manner, even with cooperative patients and experienced personnel;175,176,180,197,200 for 
instance, capillary tear collection by Markoulli et al. resulted in tear secretion that was approximately 4-
fold faster than basal tear flow in humans (4.6 vs. 1.2 µL/min, respectively).109,180 Of note, sampling itself 
may act as a stimulant due to environmental factors (air movement, light)200 and the stress/anxiety 
experienced by patients when capillary tubes are used.173,176,179,197 Importantly, the technical challenge of 
capillary tubes is amplified in animals given their uncooperative nature, and in any patient with aqueous 
tear deficiency given the low tear volume; tear sampling can be extra slow in these cases, possibly 
impeded/interrupted if an air bubble or mucinous material enters the capillary lumen.185  
Taken together, although direct tear collection remains the preferred method of some investigators 
given the ‘undisturbed’ tear sample retrieved,199 the serious drawbacks listed above have prompted a 
growing number of clinicians and researchers to consider indirect tear sampling in humans as suitable 
alternatives.149,176 It is the authors’ opinion that indirect tear sampling is also preferred in dogs, cats and 
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laboratory animals. Ultimately, the patient’s safety and comfort during tear collection is paramount and, as 
suggested by Berta, ‘it is better to use well-controlled methods than to try to cause as little irritation as 
possible’.200  
 
3.2. Indirect tear sampling 
 
Indirect techniques involve tear fluid absorption with either Schirmer tear strips or absorbent sponges, 
followed by extraction of tear compounds by centrifugation and/or solvent elution. 
Schirmer tear strips are routinely used to measure tear volume for clinical assessment of dry eye disease 
in humans and veterinary species.165,201-206 The strips are made of Whatman no. 41 cellulose filter paper and 
possess specific characteristics to promote tolerance (5mm width x 35mm length, 0.22 mm thick, 20-25 µm 
porosity, foldable extremity for ease of insertion).197,207 In addition to their conventional use for aqueous 
tear assessment, Schirmer strips can retrieve tear fluid for bioanalytical purposes in 
humans,144,161,165,166,173,176,208 dogs,143,149,156,159,160,186,209 and small laboratory species.191,210,211 For instance, 
Schirmer strips were used for in-depth characterization of proteomics in human162 and canine tears,149 and 
can also successfully recover specific analytes such as cytokines,208,212 clusterin,144 and xenobiotics.156,158-
160,191,213  
Absorbent sponges exist in different material types such as cellulose,179,181,214,215 polyvinyl 
acetal,143,159,173,181,191,214,216,217 polyester,185,188,217 and polyrurethane.181 A material with hydrophilic and 
hydrophobic properties (eg., polyvinyl acetal, polyurethane)181,214 is generally preferred in order to optimize 
the amount of fluid absorbed and the amount of fluid retrieved from the sponge. For tear fluid collection, 
the sponge is held against the lacrimal lake by the operator (to minimize reflex tearing),179,185,188,191,217 or 
placed beneath the lower eyelid for a given period of time.159,181,214 Tear fluid recovered from absorbent 
sponges can be assayed for selected tear compounds, similar to Schirmer strips. 
Indirect tear collection is superior to direct capillary sampling in many aspects, namely: (i) Improved 
tolerance and acceptability by patients;144,176,217,218 (ii) Ease of use and operator safety, especially for 
Schirmer strips, allowing non-specialists to perform the procedure with minimal training;176,181,217 and (iii) 
Larger volume of tears collected in a shorter duration.179,181,185,191 Absorbent materials collect tears but can 
also pick up cellular and extracellular ‘debris’, an attribute considered beneficial by some as the sample 
obtained is more representative of the dynamic microenvironment at the ocular surface,219 but also 
perceived as a limitation by others as the fluid retrieved is not ‘pure’ tears.199 On this note, the main 
limitation of indirect sampling is the ‘invasiveness’ of the technique, at risk of promoting reflex tearing and 
altering the composition of the tear fluid; indeed, several studies showed variable tear composition between 
directly- and indirectly- collected samples, with notable differences in the qualitative and quantitative 
profiles obtained for tear lipids167 and tear proteins.161,166,182,220 Another important drawback is related to the 
adsorptive properties of Schirmer strips or absorbent sponges, ie. incomplete release of tear compounds 
following extraction;143,159,207,208,216 however, the authors believe this limitation can be minimized/controlled 
with adequate precautions (see section 3.3). 
 
3.3. Proposed strategy for lachrymal determinations in dogs 
Schirmer strips vs. absorbent sponges – Sponges can rapidly absorb up to 106 µL of tear fluid in dogs,214 
while the maximum absorptive capacity of Schirmer strips is ~ 31 µL (ie., 35 mm wetness).221 With sponges, 
however, the operator can only control the duration of tear collection and not the volume of tears soaked 
up in each individual. The resulting variability in tear volume absorbed often translates into large intra- and 
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inter-subject variability in the concentration of the compound(s) of interest, as shown for protein content143 
and various drugs such as doxycycline,159 minocycline,222 voriconazole,223 and ofloxacin.191 On the other 
hand, the ability to control the volume of tears absorbed with Schirmer strips (ie., same mm mark) generally 
improves the reproducibility of the results.143,159,160,224  
As such, the authors prefer (i) absorbent sponges for collecting large volumes of tears in canine subjects – 
ie., for further use as blank tears in bioanalytical assays for example – and (ii) Schirmer strips for collecting 
known amounts of tears in any scenario where reproducibility of the data is important (ie., for group 
comparisons, or follow-up of the same individual over time). 
 
Schirmer strips for protein quantification – For consistency purposes, the authors recommend the use of 
dye-free Schirmer tear strips, being consistent with the manufacturer and lot number (given the reported 
variability in absorptive and adsorptive properties among Schirmer strips),225,226 as well as the time of 
collection (eg., morning)176, because of known diurnal variability in lacrimal protein composition in 
humans182,197 and dogs.224 The distal end of the Schirmer strips should remain in position (ventrolateral 
conjunctival fornix) until 20 mm, 25 mm or 30 mm wetness is reached.160,186,209,221,224 Strip wetness < 20 
mm is discouraged given the potential ‘concentrating effect’ of the absorbent filter with low tear volumes,143 
while complete wetness of the strip (35 mm) should be avoided as the total protein content is significantly 
greater with 35 mm compared to 20-30 mm mark,221 likely due to vascular fragility and excessive irritation 
ensued by the prolonged test duration. Importantly, investigators should be consistent with the selected 
mm- mark (strip wetness) within and between patients in order to standardize the volume of tears collected 
among subjects. This strategy provides a lower coefficient of variability in tear protein content compared 
to ophthalmic sponges143 and capillary glass tubes224 in dogs, thereby improving the reliability and 
reproducibility of the data. Tear extraction and protein analysis can be done directly after tear collection, 
or can be postponed to a future date as long as Schirmer strips are stored immediately at -80°C and the 
stability of the compound(s) of interest is verified.197 Following tear extraction with 
centrifugation,143,176,221,224 elution in solvent,144,149,161,162,186 or a combination of both,208,227 total protein 
content (TPC) should be quantified in order to standardize the amount of sample used for subsequent 
analyses.149,162 The authors’ preferred method is infrared spectroscopy with Direct DetectTM (EMD 
Millipore, Danvers, MA) as the technique utilizes merely 2 µL of tear sample, without any of the drawbacks 
of colorimetric protein assays (eg., Bradford, Lowry), including variability with specific protein 
composition and potential contamination from the absorbent material.179,228  
 
Schirmer strips for drug quantification – The following steps should be considered to optimize drug 
quantification in pharmacological studies: 
 
• Study design: In studies that assess tear film pharmacokinetics following topical drug administration, 
one must consider a potential limitation associated with Schirmer strips which remove most of the tear 
fluid in early collection times, thereby negatively impacting the ‘true’ tear concentration at later time 
points.197 For this reason, the authors recommend to conduct pharmacokinetic studies in tears over 
several days (eg., 10 days for 10 collection time points), repeating topical administration each day with 
a standardized volume and limiting the collection to a single time point per day. An alternative is to use 
a larger sample size and randomly allocate each time point to a subset of individuals or eyes (eg., 40 
eyes with n = 5 eyes for 8 separate time points),156 although this method should account for differences 
between subjects such as greater tear volumes in dogs of larger body weight.111  
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Another aspect to consider in the study design is the assessment of drug kinetics in diseased eyes, 
rendering the study results more clinically applicable (see section 4.2); in fact, tear film concentrations 
and ocular bioavailability are likely to differ in healthy vs. diseased eyes (eg., excessive lacrimation, 
increased absorption into congested conjunctival vessels, albumin binding),160,229 yet the majority of 
ocular studies to date are conducted in healthy individuals which is a clear limitation for translation of 
research findings from bench to bedside. 
 
• Tear collection with Schirmer strips: It is important to homogenize the volume collected within and 
between subjects by standardizing the extent of strip wetness (≥ 20 mm mark) – this approach limits 
the variability in tear concentrations related to the collection method itself.159,160 The amount of wetness 
is then converted to a volume (µL) in order to calculate actual tear film concentrations;221 data reporting 
is otherwise limited to µg/g of strip.156,191 In dogs, the median volume absorbed by Schirmer strips is 
18 µL (20 mm), 22 µL (25 mm), 26 µL (30 mm) and 31 µL (35 mm), information obtained from 
hundreds of in vivo collections with pre- and post- weighing of Schirmer strips).221 This method is 
preferred over in vitro use of phosphate buffered saline208 given differences in fluid viscosities and the 
inability of an in vitro experiment to mimic the complex dynamics of tear absorption noted in vivo (eg., 
rapid initial uptake,204 tear evaporation). 
In parallel, investigators should record the duration of tear collection (eg., 50 seconds to reach 20 mm) 
in order to calculate a flow rate (µL/min) for each sample obtained.159,180 In one of our experiments 
with doxycycline in dogs, flow rate did not influence tear concentrations,159 but this finding might not 
be generalizable to other drugs and/or other species of interest. 
 
• Extraction protocol optimization: A drug can be extracted from Schirmer strips via centrifugation, 
solvent elution, or a combination of both methods. However, a single extraction protocol cannot be 
generalized to all pharmacological studies as the specific physicochemical properties of each drug (eg., 
molecular weight, lipophilicity) can affect the extraction efficiency from the filter papers.207 As such, 
investigators should consider conducting a preliminary experiment to determine the optimal extraction 
protocol for the drug studied, and report specific recovery rates (mean ± standard, range). For instance, 
the recovery of prednisone and prednisolone was maximized with a combination of centrifugation and 
elution in methyl tert-butyl ether, a solvent chosen over methanol and acetonitrile based on superior 
drug extraction from Schirmer strips (Figure 4).160 Of note, a comprehensive review of all reported 
protocols is beyond the scope of the present work, and further research is warranted to assess the 
potential benefits (or lack thereof) of extraction steps reported in the literature, such as cutting Schirmer 
strips into small pieces162,165,213 or using ultrasonic agitation.160,165,197 Ultimately, an optimized 
extraction protocol is important as it enhances the reliability of the data at hand, improving the 
sensitivity of the bioassay, and providing drug concentrations closer to ‘true’ biological levels in the 
tear film.  
 
• Bioanalytical method optimization: First, internal standard should be applied directly onto the dry 
portion of the Schirmer strip (Figure 4),160 ie. before tear extraction instead of post-elution with solvent 
as routinely described;156,213 this step allows for drug quantification to account for potential variability 
in extraction efficiency between samples. Second, the standard calibration curve solutions should be 
constructed by spiking known drug concentrations and internal standard onto Schirmer strips, followed 
by the same extraction protocol as for biological samples; this step is equivalent to ‘spike and recover’ 
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experiments recommended for other analytes such as cytokines216 and proteins.207 Third, actual tear 
fluid should be used whenever possible as the selected matrix for standard calibration curve and quality 
control solutions,159,160,223 as the reported surrogates (eg., artificial tear solution)230 do not account for 
chemical interferences and matrix effects that typically occur with a complex biological fluid (eg., 
ionization suppression).223 Blank tears can be collected with absorbent materials prior to study 
initiation, retrieving up to 84 µL in 1 min with ophthalmic sponges in dogs214 and 132 µL in 12 min 
with successive substitutions of polyurethane mini-sponges in humans.181 
 
4. Spontaneous and experimental models of ocular surface disorders in dogs  
 
4.1. Spontaneous ocular surface diseases in dogs with translational applications to humans  
 
Spontaneous ocular surface disorders are common in dogs and represent one of the major causes for referral 
visits to veterinary practitionners.231 In contrast, naturally-acquired ocular surface pathology is much less 
common in rabbits232,233 and is rare in mice and rats.234-236  
 
4.1.1. Keratoconjunctivitis sicca 
Keratoconjunctivitis sicca (KCS), or ‘dry eye’, represents one of the most common ocular diseases in 
humans with an estimated prevalence ranging from 5 to 50% in different regions worldwide.237 The disease 
is also very common in dogs (prevalence 1.5 to 35%),231 although not a single report of spontaneous KCS 
case exists in laboratory animals such as rabbits, mice and rats.  
The pathogenesis of KCS is very complex, involving diverse physio-anatomical factors such as lacrimal 
gland integrity, meibomian glands function, hormonal balance and neuronal input.237 Numerous models of 
dry eye have been established in animals over the years,238-240 helping to elucidate complex pathological 
mechanisms involved in KCS and develop novel therapeutics for humans. However, the major drawbacks 
of most animal models are the acute nature of the induced pathology (vs. chronic disease in humans) and 
the focus on a single component of the lacrimal functional unit, such as surgically removing the lacrimal 
gland in mice to reduce tear secretion,32 cauterizing the lid margin in rats to induce meibomian gland 
dysfunction,241 or instilling topical 1% atropine in rabbits to disrupt the efferent neural input.242 These 
experimental models can be generally improved by increasing the number of interventions in the study 
animals, for instance combining lacrimal glands removal with chemical destruction of the conjunctiva in 
rabbits,243 or combining scopolamine administration with desiccating environmental stress in mice; yet, 
these complex models remain suboptimal at best given the acute nature and the inability to fully encompass 
the complexity of KCS pathophysiology.244 Dogs, on the other hand, develop KCS in a spontaneous manner 
and do not require invasive procedures to disrupt the lacrimal functional unit.201,205 Most importantly, the 
disease is clinically and immunopathologically similar to dry eye in humans, and possesses several 
attributes that are beneficial for translational research: 
 
• Canine KCS is typically bilateral, develops in middle-aged animals, is more common in female dogs 
and in certain breeds (eg., American Cocker spaniel, English Bulldog), mimicking the diversity of dry 
eye in humans related to sex and race.201,237 
• Immune-mediated dacryoadenitis is the most common etiology of KCS in dogs – similar to human 
patients with Sjögren’s syndrome – in which progressive lymphocytic infiltration of the lacrimal 
gland(s) damages the secretory tissues and reduces aqueous tear production.201 
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• Meibomian gland dysfunction is recognized in many canine patients with ocular surface disorders, 
affecting tear film stability in a similar manner than evaporative dry eye in human patients.245  
• Spontaneous symptoms of ocular irritation, conjunctival hyperemia and corneal scarring correlate 
directly with aqueous tear production, a parameter that is easily measured/quantified using a standard 
Schirmer tear test strip. 
• Multiple diagnostic tools used in humans can easily be applied in dogs (but not rodents) given the large 
size of the canine globe,205,239 including tear osmometry, vital staining, strip meniscometry test, infrared 
meibography and corneo-conjunctival impression cytology. 
• Dogs and humans display a similar responses to common therapeutics for dry eye disease; in fact, the 
two FDA approved anti-inflammatory drugs for dry eye disease in humans (cyclosporine, lifitegrast) 
were first developed in canine patients with spontaneous KCS.201,246 
 
The main limitation to consider in dogs is the tendency for clinical signs to be more pronounced in that 
species vs. humans (eg., tenacious mucoid discharge, corneal melanosis, neovascularization), in part 
because canine KCS is often diagnosed at a later stage when owners fail to recognize more subtle clinical 
signs early on. 
 
4.1.2. Allergic conjunctivitis  
Allergic conjunctivitis is a common disorder in humans with an approximate prevalence of 40% in the 
North American population.247 The disease is characterized by an immunopathological reaction of the 
ocular surface to the external environment, resulting in clinical symptoms that range from mild 
conjunctivitis (seasonal or perennial) to the more severe, vision-threatening vernal keratoconjunctivitis and 
atopic keratoconjunctivitis.247 Over the past few decades, extensive research on small laboratory species 
(mice, rats, guinea pigs) has helped elucidate some of the complex molecular and cellular processes 
involved in the pathogenesis of ocular allergies.248,249 However, these experiments primarily relied on a 
relatively small selection of allergens (eg., ovalbumin, compound 48/80, ragweed pollen), using an 
experimental design that merely mimics acute forms of the disease – not chronic allergen exposure over 
months to years – therefore limiting the long-term clinical significance of these findings. On the other hand, 
dogs possess notable benefits for the comparative study of allergic conjunctivitis, especially when 
considering companion animals rather than laboratory Beagles: (i) these animals share the same 
environment (and related allergens) as their human owners, unlike commonly used species who are housed 
in a laboratory setting; (ii) companion dogs are outbred, providing a genetic diversity background that better 
reflects the human population than inbred laboratory species; and (iii) dogs develop a spontaneous form of 
allergic conjunctivitis. Spontaneous allergic conjunctivitis is relatively common in dogs, often associated 
with other allergic disorders such as canine atopic dermatitis.250 Similar to humans, the clinical signs of 
allergic conjunctivitis involve conjunctival hyperemia, chemosis, pruritus and ocular discharge, the disease 
can be diagnosed with high sensitivity and specificity using the conjunctival provocation test,250 and similar 
therapeutics are used in both species including topical antihistamines, mast-cell stabilizers, NSAIDs and 
immunomodulators.247 
 
4.1.3. Microbial keratitis 
 
It is well recognized that a natural host is best suited for studying infection, as several species-specific 
factors (eg., anatomical, physiological, genetic, immune) closely influence the host-pathogen interactions 
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and subsequent clinical response.251 These factors likely explain why rabbits and rodents – traditionally 
used to model ocular surface infections in humans – cannot fully recapitulate the disease presentation and 
progression that occur in human patients.252,253 As such, there is an emerging appreciation for the 
translational advantage of studying spontaneous (and not experimental) ocular infections in dogs:  
 
• Herpetic keratitis: Recent work has highlighted the robustness and reproducibility of the canine model 
to study ocular herpesvirus infections and disease,253,254 showing striking similarities in the 
pathogenesis of canine herpesvirus-1 and herpes simplex virus-1, both members of the 
alphaherpesvirinae subfamily with a seroprevalence of 21-98% in dogs (CHV-1) and 67-90% in 
humans (HSV-1).253 
• Bacterial keratitis: The most common bacterial genera isolated from canine patients overlap with the 
ones recognized in human patients (Staphylococcus, Streptococcus, Pseudomonoas).255,256 In fact, the 
major culprit in canine bacterial keratitis (Staphylococcus pseudintermedius) is now considered an 
emerging zoonosis in humans.257 
 
4.1.4. Others 
 
Dogs can serve as models for other ocular surface diseases such as corneal endothelial dystrophy (analogous 
to Fuch’s dystrophy in humans),258 limbal stem cell deficiency,259 ocular surface squamous neoplasia260 and 
neurotrophic keratopathy,261 among others. 
 
4.2. Breakdown of the blood-tear barrier in dogs: A model for ocular pharmacology and 
therapeutics 
 
4.2.1. Histamine-induced conjunctivitis  
 
To date, the vast majority of preclinical ocular studies for evaluation of candidate drug efficacy and safety 
are conducted in healthy eyes – in part for simplicity, but at a higher risk of treatment failure rate when 
translating these findings to clinical studies. Indeed, healthy eyes do not account for the disruption of ocular 
homeostasis that occurs with inflammatory diseases, including (but not limited to) changes in tear film 
dynamics, tear composition and permeability of ocular tissues. To address this shortcoming, the authors 
have recently established a robust in vivo model of conjunctivitis in dogs, a translational large animal model 
that provides a unique opportunity for scientists to investigate the ocular surface in health and disease 
states.212 The model specifically focused on conjunctivitis as this condition is frequently encountered in 
humans and dogs,262,263 developing either as a primary condition (eg., bacterial, viral), or as a bystander to 
common ophthalmic diseases such as blepharitis, keratitis, uveitis and glaucoma. This model is particularly 
appealing given the low cost, non-invasiveness, self-resolving nature, ability to adjust the duration and 
severity of the disease, and shared features with naturally occurring diseases in human and veterinary 
medicine.  
 
The main highlights of the translational ‘large animal’ model are as follows: 
 
• The selected compound (histamine) is inexpensive and triggers local inflammation in a non-specific 
manner. 
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• Disease severity is dose-dependent, allowing investigators to induce mild (1 mg/ml), moderate (10 
mg/ml) or severe (375 mg/ml) conjunctivitis (Figure 5). 
• Disease duration is dose-dependent, self-resolving within an average of 115 min (1 mg/ml), 190 min 
(10 mg/ml) or 390 min (375 mg/ml). The duration of conjunctivitis can be lengthened by repeating 
topical histamine administration at set intervals.160  
• Topical histamine is safe and generally well-tolerated, although selected eyes receiving the highest dose 
of histamine (375 mg/ml) can develop mild ocular irritation (lasting < 1 min), blepharitis or miosis. 
• Tear film composition changes in eyes with experimentally-induced conjunctivitis (eg., higher levels 
of serum albumin and inflammatory cytokines), mimicking clinical patients with ocular surface 
inflammation. 
• A transient increase in tear quantity and decrease in tear quality occur, although tear film homeostasis 
is rapidly restored in ≤ 5 min.264  
 
Levels of serum albumin are increased in tear film of canine eyes with experimentally-induced or naturally-
acquired conjunctivitis,212,224 a physiological variation caused by the breakdown of the blood-tear barrier 
(Figure 6). Disruption of the blood-tear barrier is also described in human patients with spontaneous ocular 
surface disorders (eg., dry eye, allergic conjunctivitis)182,265-267 and other animal species (rabbits, horses, 
guinea pigs).268-270 Increased vascular permeability and disruption of tight junctions between conjunctival 
epithelial cells likely play a role (Figure 6),271,272 although the exact etiopathogenesis is unknown and 
require further investigation. A few noteworthy limitations are listed here: (i) the model is not adequate to 
study ocular allergy given the lack of characteristic features noted in canine patients with allergies (eg., 
follicular conjunctivitis); (ii) pro-inflammatory mediators other than histamine are also responsible for 
triggering conjunctival inflammation in clinical patients (eg., leukotrienes, cytokines); (iii) conjunctival 
inflammation is relatively short-lived (115-390 min) and cannot mimic the physiological changes noted in 
patients with chronic conjunctivitis (eg., reduced goblet cell density).  
 
4.2.2. Clinical relevance of serum albumin leakage in tear film 
 
Elevated serum albumin levels in the tear film represents a biomarker for ocular insult or inflammation in 
humans, dogs and other species.182,212,265,270 In brief, plasma-derived albumin leaks onto the ocular surface 
from congested conjunctival vessels and mixes with the tear film; as such, albumin concentration in tears 
is generally low in healthy state but increases substantially in diseased eyes.182 For instance, a recent study 
showed that canine eyes with diverse ocular diseases (eg., corneal ulcer, uveitis, glaucoma) had lacrimal 
albumin levels that were up to 14.9-fold greater than contralateral healthy eyes.212 Albumin is a relatively 
large protein that has a remarkable capacity for binding ligands.273 At the level of the eye, protein binding 
represents an important restriction to drug absorption as only the unbound fraction of the drug diffuses 
across the ocular tissue barriers.268 Combined with the rapid drainage of tears following eyedrop 
administration (in humans/dogs, not true in rabbits), any portion of drug that binds to albumin in tear film 
can be considered as ‘lost’ from a pharmacological standpoint. Broader implications of the blood-tear 
barrier breakdown on ocular drug pharmacokinetics are listed below: 
 
• Reduced bioavailability for intraocular targets: The inability of bound therapeutic drugs to penetrate 
the cornea lowers the amount of drug available inside the eye to exert its pharmacological action. The 
physiological effects of increased albumin levels in tears was recently demonstrated with tropicamide 
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(and to a lesser extent latanoprost) in dogs,229 as well as pilocarpine in rabbits.268 Of note, the impact of 
lacrimal albumin on the pharmacological activity of a given drug is likely modulated by various factors, 
the concentration of the formulation, the mechanism of action and the potency of the drug for its 
biological target.229  
 
• Reduced bioavailability for ocular surface targets: Drug-albumin interactions in the tear film could 
also be detrimental for management of ocular surface disorders, for instance reducing the efficacy of 
therapeutics for bacterial keratitis as only the unbound portion of an antibiotic is microbiologically 
active.274 Preliminary experiments conducted by the authors showed that the presence of albumin results 
in higher minimal inhibitory concentrations (ie., reduced susceptibility) for various antibiotics against 
common bacterial isolates in dogs (in-house unpublished data).  
 
• Tear film concentrations of systemically administered drugs: Drug in the plasma compartment can 
access the tear film by active secretion from the lacrimal gland, or passive diffusion through the 
conjunctival vessels. The latter is theoretically enhanced when the blood-tear barrier is disrupted. In 
humans, this physiological feature could explain why the concentration-time profiles of cetirizine were 
similar in serum and tears in patients with allergic conjunctivitis.157 In dogs, tear film corticosteroid 
levels were generally higher in conjunctivitis vs. control eyes following oral prednisone administration 
(up to +64%), although differences were not statistically significant.160 The degree of conjunctival 
permeation is likely to vary among therapeutic drugs given differences in their physico-chemical 
properties.275,276 
 
These findings highlight the importance of conducting pharmacological studies in clinically relevant 
preclinical species that are able to recapitulate leaky conjunctival vessels and elevated albumin levels in the 
tear film of clinical patients with ocular diseases. For topical drug administration, the authors recommend 
using an experimental model of blood-tear barrier breakdown (eg., histamine-induced conjunctivitis or 
alkali burn models)212,277 so that albumin and other relevant proteins are already present on the ocular 
surface at the time the drug mixes with the tear film.229 For systemic drug administration, the authors suggest 
conducting a preliminary experiment to assess whether conjunctival inflammation affects tear film 
concentrations to a significant extent. If not, pharmacological assessment in healthy eyes should be 
sufficient. Incidentally, the physico-chemical properties of some drugs (eg., size, lipophilicity, polar surface 
area)275,276 may allow for high conjunctival permeation under normal conditions, thereby rendering 
differences between healthy vs. diseased eyes insignificant. 
 
4.3. Corneal injury in dogs: in vivo and ex vivo models 
 
Corneal injury is common in human and veterinary patients – whether due to trauma, surgery, or other 
causes – and the resulting corneal scar remains one of the leading causes of blindness in animals and people 
worldwide.278 Although small laboratory animal species are commonly used in corneal scarring research,279 
results derived from these models have several limitations. The corneal thickness is much smaller in rabbits 
and rodents compared to humans (Table 1). In addition to thin corneas, mice and rats have corneas that are 
much smaller in diameter compared to people; consequently, it is often difficult to isolate the central cornea 
when performing the experimental procedure (eg., chemical burn) and the damage caused to surrounding 
limbal stem cells negatively impacts the wound healing process. Using the dog as an animal model is 
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therefore more appropriate, not only due to closer resemblances in ocular surface anatomy and physiology 
with humans, but also the relatively high prevalence of naturally-acquired corneal pathology in the canine 
species. In that regard, Gronkiewicz et al. recently developed a novel in vivo corneal fibrosis model in 
canines;277 the authors induced corneal scarring with an alkali burn and investigated the ability of 
suberanilohydroxamic acid (SAHA) to inhibit fibrosis using this large animal model. The availability of 
such a model presents a clear opportunity for translational research (ie., intact innervation, tear film, blood 
supply), although experimentally-induced corneal wounding (at risk of secondary infection) and subsequent 
corneal scar in dogs represent potential ethical challenges. As an alternative, other authors have established 
ex vivo canine corneal cultures that can be used to model wound healing and assess anti-fibrotic 
compounds,280-282 or better understand the pathophysiology of herpesvirus in a virus-natural-host 
environment;283 in that study, the authors established an air-liquid canine corneal organ culture model to 
study acute herpetic keratitis, showing important similarities in the response to CHV-1 to what has been 
described for HSV-1.283 
 
5. Conclusions 
 
“Considerable reservations may be felt about comparing results from rabbits with those from humans 
because of the differences between the physiology of tear flow and mixing and general anatomy. 
Nevertheless, the rabbit is the principal experimental animal in ophthalmology, so comparisons are 
needed”.284 Sadly, this quote published over 45 years ago is still representative of today’s state of 
ophthalmic research. Rabbits and small laboratory rodents continue to be used primarily (if not exclusively) 
in most areas of ophthalmic research,1 a concerning fact given the vast anatomical and physiological 
differences that exist with humans. Of note, such differences should not be regarded as merely ‘weaknesses’ 
for translational research, but rather evolutionary adaptations optimally suited to the environment and 
behavior of each species; for instance, rabbits likely developed a very stable tear film to limit intermittent 
blindness that occurs with each blink,285 thereby reducing the risk of predation. Noteworthily, recent 
innovations have helped mitigate some of the drawbacks of traditional laboratory species – for instance 
providing manual blinking and supplementary tear flow in anesthetized rabbits,286 or reverse engineering 
the ocular surface using human cells in vitro287 – however the authors believe the complexity of the ocular 
surface and integrated lacrimal functional unit cannot be fully recreated without in vivo conditions in awake 
subjects. 
 
The comparative work presented throughout this review provides evidence that dogs are best suited for 
translational research in ophthalmology. Unlike small laboratory animals, dogs share similar anatomical 
and physiological features to humans, similar environmental stressors and genetic variation, and a range of 
naturally occurring ophthalmic diseases that closely resemble clinical phenotypes in human patients. The 
resemblance between dogs and humans is particularly relevant in the field of ocular pharmacology, with 
notable similarities in blink rate, tear turnover rate (basal, reflex), volumetric capacity of the palpebral 
fissure, and other factors pertinent to drug diffusion (eg., globe volume, corneal thickness); nonetheless, a 
few differences should be accounted for in comparative studies, such as the presence of a nictitating 
membrane, greater tear volume, larger corneal size and lower corneal elastic modulus in dogs. Similar to 
other fields of medicine, preclinical studies in ophthalmology could involve canine patients with 
spontaneous ocular diseases – many of which share striking resemblances with their human counterparts – 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 23 May 2020                   doi:10.20944/preprints202005.0363.v1
integrating the expertise of veterinarians, physicians and basic science researchers under the umbrella of 
the One Health Initiative.6,288 Alternatively, or complementarily, preclinical animal work could be 
performed in laboratory dogs in whom ocular disease is experimentally-induced, making sure to account 
for the blood-tear barrier breakdown (noted in clinical patients with ‘red eyes’). In all cases, tear fluid can 
be easily collected from canine eyes for various bioanalytical purposes, favoring Schirmer tear strips over 
other collection methods given the excellent safety profile and enhanced reliability in analyte quantification 
(eg., proteins, drugs) provided by this method. 
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TABLES 
 
Table 1. Comparative anatomy of the ocular surface and globe between humans, dogs and common 
laboratory species used in preclinical ophthalmic research.  
 
  Human Dog Rabbit Mouse Rat 
Lacrimal 
glands and 
nasolacrimal 
apparatus 
Lacrimal glands 
 
Lacrimal gland 
Accessory glands 
of Wolfring and 
Krause  
20 
Lacrimal gland, 
Third eyelid 
gland  
11,14 
Lacrimal gland, 
Third eyelid gland, 
Infraorbital 
(intraorbital), 
Accessory glands of 
Wolfring  
10,11,22,23 
Infraorbital 
(extraorbital) 
10,11,22 
Infraorbital 
(extraorbital) 
10,11,22 
Lacrimal glands 
volume (cm3) † 
0.59-0.61  
18 
0.14 / 0.1  
17 
– / 1.5  
289 
– – 
Harderian gland 
Absent  
22 
Absent  
11,16 
Present  
11,22 
Present  
11,22 
Present  
11,22 
Nasolacrimal 
drainage apparatus 
Two 
puncta/canaliculi, 
no flexure  
25,27 
Two 
puncta/canaliculi, 
1 dorsal flexure  
16,25,27  
Single 
punctum/canaliculus, 
two pronounced 
flexures  
27,38,41 
Two 
puncta/canaliculi  
25 
Two 
puncta/canaliculi  
25 
Eyelids 
Third eyelid 
Absent  
66 
Present  
16,66 
Present  
66 
Present  
66 
Present  
66 
Palpebral fissure 
width (mm) 
21.3-34.5  
290 
18.9-34.1  
40,291 
10-16  
38,41,42 
3.7-5 ‡ 
43 
6-9  
45 
Interpalpebral 
fissure area (cm2) 
1.8 39 
2.2 § 
290 
1.4  
39 
0.13 ‡ 
43 
0.5 ¶ 
45 
Meibomian glands 
(/eyelid) 
20-40  
39,292 
20-40  
16 
30-50  
38,39,41 
20  
293 
20-30 # 
241 
Conjunctiva 
Conjunctival fornix 
depth (mm) †† 
15  
49 
– 
20.36  
48 
– – 
Conjunctival 
surface (cm2) 
17.65  
50 
– 
13.3-18.48 ‡‡ 
50 
– – 
Conjunctiva/Cornea 
surface ratio 
17.17  
50 
– 
8.62-8.94  
50 
– – 
Goblet cell spatial 
configuration 
Individual  
51 
Individual  
52 
Individual  
51 
Clusters  
51 
Clusters  
51 
Goblet cell 
distribution 
Highest in plica 
semilunaris and 
lower nasal 
fornix 
Low in bulbar 
conjunctiva 
30,53,54,56 
Highest in third 
eyelid and lower 
nasal fornix 
Low in bulbar 
conjunctiva 
52,55 
Highest in palpebral 
conjunctiva 
Relatively dense in 
bulbar conjunctiva 
57-59 
– 
Highest in fornix 
Low in bulbar 
conjunctiva 
Kim 2019 
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Conjunctiva-
associated 
lymphoid tissue 
Present  
61 
Present  
16,61 
Present  
61 
Only present in 
nictitating 
membrane  
61,62 
Absent  
61 
Cornea 
and 
Sclera 
Corneal diameter, 
horizontal/vertical 
(mm) 
11.8 / 11.2 
75,77 
13-17 / 12-16 
71,77 
13.4-15 / 13-14 
41,76,77 
2.3-2.6 / – 
74 
2.0-6.8 / 2.0-6.7 
44,72,73 
Corneal surface 
(cm2) 
1.04-1.3 
50 
1.2-2.1 
71,77 
1.55-2.03 
50 
0.04-0.05 h 
74 
0.27-0.36 §§ 
72,73 
Corneal thickness 
(µm) 
505-563 
79 
497-594 
68,78 
354-407 
41,76,79,80 
90-137 
11,74,80 
159-170 
68,80 
Corneal epithelial 
thickness (µm) 
44-55 
79 
52-64 
71,78 
45-49 
79 
37-46 
74 
26-33 
85 
Endothelial cell 
density (cells/mm2) 
2732 
90 
2818 
68 
3233 
68 
2875 
68 
2242 
68 
Subbasal nerve 
plexus pattern 
Whorl-like 
67 
Whorl-like 
67 
Horizontal 
67 
Whorl-like 
67 
Whorl-like 
67 
Corneal sensitivity 
(g/mm2) 
0.2-1.0 
2 
2.16-2.9 
92,95  
6.21-10 
2,92 
0.59 
93 
0.42-0.47 
91,94 
Stiffness/elastic 
modulus (kPa) ¶¶ 
16.2-33.1 
87,294 
1.3 
87 
1.1 
86 
25-40 
89 
6.2 
88 
Scleral thickness at 
the limbus (mm) 
0.50 
102 
0.80 
101 
0.29 
103 
0.05-0.06 
105 
< 0.1 
104 
Globe 
Globe volume (mL) 
5.7-6.0 
295 
5.0-5.8 
296 
2.3-2.9 
296 
0.014 j 
297 
  0.13 ## 
72 
Anterior chamber 
(mL) 
0.17-0.31 
66,77 
0.77 
101 
0.28-0.30 
41,66,77 
0.0044-0.007 
11,66,77 
0.0136-0.015 
11,66,77 
Vitreous chamber 
(mL) 
3.5-5.4 
65 
1.7-3.0 
101,296 
1.1-1.8 
66,296 
0.0053 
11,65 
0.013-0.054 
11 ,65 
 
 
– Information not available or not found  
 
† Lacrimal gland (human), Lacrimal gland / TEL gland (dog), Lacrimal gland / Harderian gland (rabbit) 
‡ Estimated based on clinical images43  
§ Estimated based on clinical images40  
¶ Calculated based on average palpebral fissure length45  
# Estimated based on clinical images241  
†† Central upper conjunctival sac (from fornix to lid margin) 
‡‡ Does not account for the nictitating membrane, surgically removed prior to the experiment 
§§ Estimated from corneal radius, assuming a circular shape for the cornea in rodents72 
¶¶ Whole cornea in rats, epithelium and anterior stroma in other species 
## Estimated from axial length, assuming a spherical shape for the globe 
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Table 2. Comparative physiology and characteristics of the ocular surface and tear film between humans, 
dogs and common laboratory species used in preclinical ophthalmic research. 
 
  Human Dog Rabbit Mouse Rat 
Ocular 
surface 
physiology 
Blink rate 
(blinks/min) 
 
8.5-17.6 
122-124 
14.2 
121 
0.05-0.19 
2,123,127 
0-4 
125,126 
2-5.3 
91,124 
Volumetric 
capacity of the 
palpebral fissure 
(µL) 
25-30 
109,136 
31.3 
40 
10-25 † 
112,138 
≤ 5 
139,140 
≤ 20 
141 
Ocular surface 
temperature (°C) 
32.8-37.1 
298,299 
35.2 
300 
39.1 
298 
37.2 
298 
36.5 
298 
Tear film 
characteristics 
Tear film 
thickness (µm) 
2.3-11.5 ‡ 
119 
15.1 
111 
6.5-18.4 
119 
7.4-21.1 
119,301 
2-12.6 
119,302 
Lipid layer 
thickness (nm) 
62-78 
123,303 
13-581 
121 
> 180 
123 
– 
12 
301 
Tear volume 
(µL) 
7-12.4 
109,115 
65.3 
111 
1.9-7.5 
112,116 
 
0.06-0.2 
113,118 
4.6 
117 
Basal tear 
turnover rate 
(%/min) 
13.1-17.5 
109,110 
12.1 
111 
6.2-7.1 
112 
5.2 
113 
– 
Reflex tear 
turnover rate 
(%/min) 
31.5-100 
109,115 
50 
111 
6.1-6.9 § 
112 
– 
 
– 
 
Evaporative rate 
(µm/min) 
3.22 
304 
– 
0.47 
127 
– – 
Tear film 
diagnostics ¶ 
Schirmer tear 
test-1 (mm) # 
10.0-18.6 
305,306 
18.1-24.3 
13,52,95,205,307,308 
4.6-7.6 
42,116,309 
– 
5.6-9.4 
91,241 
Phenol red 
thread test 
(mm/15s) 
9-20 
310 
17.5-39.2 
95,205,307,308 
20.9-25.0 
42,309 
2.8-11.2 
125,244,311 
7.6 
312 
Tear film 
breakup time 
(sec) 
7.4-13.0 
305,306 
13.9-24.0 
13,52,205,307 
2-1788 †† 
313 
5-25 
125,129 
5.2-6.0 
241 
Tear osmolarity 
‡‡ (mOsm/L) 
300.8 
202 
337.4-339.0 
205,314 
291.3 
315 
346.3-366.8 
310 
284.8 
312 
Tear pH 
7.83 
316 
8.05 
215 
8.2 
316 
7.59 
317 
– 
 
– Information not available or not found  
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† Based on greater percent of drug lost at 1 min in rabbit eyes receiving 25 or 50 µL eyedrop vs. 5 or 10 µL 
eyedrop,138 despite no changes in tear turnover rate for instilled volumes up to 50 µL112  
‡ Excludes an outlier measurement of 41-46 µm318  
§ Estimated from rabbit eyes receiving a large volume instilled eyedrop (25-50 µL) 
¶ Reported values prioritized studies that did not use sedation or general anesthesia 
# Values reported in mm/5min (humans) or mm/min (all other species) 
†† Large variability in studies’ methodology, most using topical and/or general anesthesia prior to testing, 
resulting in non-physiologic and highly variable measurements for tear film break up time 
‡‡ Measurements obtained with the same device (TearLabTM, OcuSense Inc., San Diego, CA). 
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Table 3. Comparative composition of the major components in tear film between humans, dogs and 
common laboratory species used in preclinical ophthalmic research. 
 
  Human Dog Rabbit Mouse Rat 
Proteins 
 
Lactoferrin † 
Abundant 
144,147 
Low 
146,147 
Low 
319,320 
Low 
147 
Low 
147 
Lysozyme 
Abundant 
144,147 
Low 
145,146 
Low 
190,319 
Low 
147 
Low 
147 
Lipocalin ‡ 
Abundant 
144,147,148 
Low 
to moderate 
146,147,149,150 
Low 
147,148,319,321 
Low 
147,198 
Absent 
147,148 
Lacritin 
Moderate 
144 
Moderate 
322 
– 
Absent 
198 
Present 
323 
Secretory IgA 
Moderate 
144 
Moderate 
146,324,325 
Present 
22 
Low 
11 
Moderate 
326 
Serum 
albumin 
Low 
182 
Low 
146,150,212 
Low 
190,319 
Present 
198 
– 
Peroxidase 
Low 
327 
Low 
146,325 
Absent 
190 
– 
Abundant 
194  
Amylase 
Low 
327 
– 
Absent 
190 
– 
Low 
194 
Mucins 
 
MUC5AC 
Present 
11 
Present 
11,55 
Present 
11 
Present 
11 
Present 
11 
MUC1, 
MUC4, 
MUC16 
MUC16 >> 
MUC1 > 
MUC4 
153 
MUC16 >> 
MUC1 > MUC4 
153 
MUC1 ≈ 
MUC4 ≈ 
MUC16 
153 
Present 
328 
Present 
329 
Major O-
glycans 
Sialylated 
glycans 
154 
Fucosylated 
glycans 
154 
Fucosylated 
glycans 
154 
– – 
Lipids 
 
Wax esters 
Abundant 
129,155 
Abundant 
129,155 
Low 
129 
Abundant 
129 
Present 
330 
Cholesterol 
Low 
129,155 
Low 
129,155 
Low 
129 
Low 
129 
Abundant 
330 
Cholesteryl 
esters 
Abundant 
129,155 
Abundant 
129,155 
Low 
129 
Abundant 
129 
– 
DiHL 
Low 
129,155 
Low 
129,155 
Low 
129 
Low 
129 
– 
DiHL esters 
Low 
129,155 
Low 
129,155 
Abundant 
129 
Low 
129 
– 
DiAD 
Low 
129,155 
Low 
129,155 
Abundant 
129 
Low 
129 
– 
OAHFA 
Abundant 
129,155 
Abundant 
129,155 
Abundant 
129 
Abundant 
129 
– 
Chl-OAHFA 
Moderate 
129,155 
Moderate 
129,155 
Low 
129 
Moderate 
129 
– 
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Others § 
Low 
129,155 
Low 
129,155 
Low 
129 
Low 
129 
– 
 
– Information not available or not found 
† Homologous iron-binding protein called transferrin is reported in dogs146 and rabbits319  
‡ Homologous proteins are reported in dogs (major canine allergen),148-150 rabbits (lipophilin)151 and rats 
(VEGr1)148  
§ Triacylglycerol, squalene, ceramides, phospholipids and sphingomyelins. 
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FIGURES AND FIGURE LEGENDS 
 
Figure 1. Graphical representation of the canine ocular surface and lacrimal functional unit. 
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Figure 2. Diagram depicting the complexity of tear film dynamics and ocular surface physiology. Secretion of tear components, distribution of tears 
through blinking, and elimination through nasolacrimal drainage and evaporation must be precisely regulated to maintain homeostasis. Drug kinetics 
following topical eyedrop administration are impacted by key parameters highlighted in yellow, each being unique in different species. Adapted 
with permission from “Tsubota K, Tseng SCG, Nordlund ML. Anatomy and Physiology of the Ocular Surface In: Holland EJ,Mannis MJ, eds. 
Ocular Surface Disease Medical and Surgical Management. New York, NY: Springer New York, 2002;3-15”. 
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Figure 3. Tear collection in dogs using microcapillary glass tubes (a), Schirmer tear strips (b) or absorbent sponges (c). 
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Figure 4. Step-by-step protocol to exact tear fluid from Schirmer strips for analytical purposes, using a combination of centrifugation and solvent 
wash. Centrifugation of wetted Schirmer strip (containing tear sample and internal standard) retrieves tear fluid in a large tube, while subsequent 
solvent elution washes residual content from the absorbent filter paper.  
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Figure 5. Representative clinical pictures of mild conjunctivitis (a), moderate conjunctivitis (b), and severe conjunctivitis (c) in dogs following 
topical administration of histamine at concentrations of 1 mg/mL, 10 mg/mL and 375 mg/mL, respectively. Reprinted from “Sebbag L, Allbaugh 
RA, Weaver A, et al. Histamine-Induced Conjunctivitis and Breakdown of Blood-Tear Barrier in Dogs: A Model for Ocular Pharmacology and 
Therapeutics. Front Pharmacol 2019;10:752”. 
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Figure 6. Graphical representation of the blood-tear barrier in the canine eye. The barrier is intact in healthy eyes (left) but is disrupted in diseased 
eyes (right), enhancing the flow of compounds (eg, albumin, xenobiotics) between the tear film and the blood compartments. Breakdown of the 
blood-tear barrier can have important clinical implications such as enhanced systemic absorption from greater conjunctival vascular permeability, 
or reduction in ocular drug bioavailability due to drug-albumin interactions in the tear film. 
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